查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594390

NGS 样品製备市场：按产品、工作流程、技术、应用和最终用户 - 2025-2030 年全球预测

NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (DNA, Library Preparation, Quality Control), Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年NGS样本製备市场价值为24亿美元，预计2024年将达27.8亿美元，复合年增长率为16.01%，到2030年将达68亿美元。

下一代定序 (NGS) 样品製备包括製备用于定序的核酸所需的所有步骤，包括萃取、精製、片段化和文库建构。这部分对于整个 NGS 流程至关重要，因为它可确保下游结果的样本品质和准确性，促进基因组研究、医学诊断和个人化医疗中的应用。由于临床诊断、感染疾病监测和癌症基因组分析的需求不断增加，NGS 市场正在经历显着增长。主要成长动力包括可实现更高通量和准确性的技术进步、基因组研究的扩散以及定序成本的下降。此外，人工智慧和自动化在样品製备过程中的集成为市场参与者提供了提高效率和减少错误的有利可图的机会。然而，市场成长面临初始设置成本高、监管复杂性以及需要熟练人员运作先进 NGS 平台等挑战。对于中小型企业来说，这些障碍可能尤其繁重。儘管面临这些挑战，创新仍然强劲，有前景的研究领域包括开发标准化、易于使用的套件和耗材，可以更有效地处理不同的样品。鼓励公司专注于伙伴关係和协作研究，以扩大其技术能力并整合创新方法，例如用于微流体样品製备的实验室晶片系统。对竞争格局的回顾表明，市场竞争激烈且发展迅速。保持技术前沿并提供可客製化且经济高效的解决方案对于业务成长至关重要。 NGS 样品製备市场的本质是动态的，并受到不断的技术突破和应用扩展的推动。

主要市场统计
基准年[2023] 24亿美元
预测年份 [2024] 27.8亿美元
预测年份 [2030] 68亿美元
复合年增长率（%） 16.01%

市场动态：揭示快速发展的 NGS 样品製备市场的关键市场洞察

NGS 样品製备市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病的流行和早期诊断的需求日益增长
    • 新治疗方法研发的 NGS 投资情况良好
    • 扩大NGS测序技术在农业领域的应用以实现永续生产力
  • 市场限制因素
    • NGS样品製备平台高成本以及NGS样品製备过程中的污染问题
  • 市场机会
    • NGS 样品製备平台的技术进步
    • 加强私营和政府组织之间的协作和伙伴关係，以开发 NGS 样品製备平台
  • 市场挑战
    • 中小型实验室缺乏熟练的专业人员

波特五力：驾驭 NGS 样品製备市场的策略工具

波特五力框架是了解 NGS 样品製备市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 NGS 样品製备市场的外部影响

外部宏观环境因素在塑造 NGS 样品製备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 NGS 样品製备市场的竞争格局

NGS 样品製备市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 NGS 样品製备市场供应商的绩效评估

FPNV定位矩阵是评估NGS样本製备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了 NGS 样品製备市场的成功之路

NGS 样品製备市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病传播日益蔓延，需要早期诊断
      • NGS 研究和开发新治疗方法的有利投资环境
      • NGS定序技术在农业中的新用途，以实现永续生产力
    • 抑制因素
      • NGS样品製备平台高成本以及NGS样品製备过程中的污染问题
    • 机会
      • NGS 样品製备平台的技术进步
      • 加强私营和政府组织之间的合作和伙伴关係，开发 NGS 样品製备平台
    • 任务
      • 中小型实验室缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 NGS 样品製备市场：副产品

  • 试剂/耗材
  • 工作站

第七章 NGS 样品製备市场：依工作流程

  • DNA
    • 人类全基因组序列分析（WGS）
    • 标靶定序
    • 全EXOME定序 (WES)
  • 准备图书馆
  • 品管
  • RNA
    • 基因表现分析
    • 全转录组序列分析
  • 靶向序列捕获
    • 目标序列
    • 韦斯
    • 全EXOME定序 (WES)

第八章 NGS 样品製备市场：依技术分类

  • 离子半导体定序
  • 奈米孔定序
  • 边定序边定序 (SBS)
  • 单分子即时 (SMRT)定序

第九章 NGS 样品製备市场：依应用分类

  • 农业和动物研究
  • 疾病诊断
    • 癌症诊断
    • 感染疾病诊断
    • 生殖健康检查
  • 药物发现

第 10 章 NGS 样品製备市场：依最终用户分类

  • 学术机构与研究中心
  • 医院/诊所
  • 製药和生物技术公司

第十一章 美洲NGS样品製备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区NGS样本製备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲NGS样品製备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 安捷伦改善了 NGS 样品製备工作流程的使用者体验
    • INTEGRA Biosciences 收购 Miroculus
    • Ultima Genomics 与 New England Biolabs 合作扩大 Ultima 定序仪的研究应用
    • QIAGEN 完成对 Verogen 的收购，利用 NGS 技术加强人类 ID/法医学领先地位
    • 安捷伦宣布收​​购用于癌症研究的高性能 NGS靶向序列捕获工作流程开发商 Avida Biomed
    • 整合式 DNA Technologies 推出完整的猴痘 NGS 文库製备解决方案
    • 推出 NGS KAPA靶向序列捕获产品
    • PerkinElmer 推出 BioQule NGS 系统来自动化文库製备
    • 隆重介绍 Tecan 的 MagicPrep NGS - 满足您的 NGS 文库製备需求的即用型解决方案
    • Beckman Coulter Life Sciences 与 Illumina 签署 Biomek NGeniuS 系统应用开发协议
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Applied Biological Materials Inc.
  • Aurora Biomed Inc.
  • Beckman Coulter by Danaher Corporation
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDynami
  • Eppendorf SE
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd.
  • FORMULATRIX, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Macrogen Inc.
  • Magen Biotechnology Co., Ltd.
  • MCLAB
  • Merck KGaA
  • New England Biolabs, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer Inc.
  • Promega Corporation
  • Psomagen, Inc.
  • Qiagen NV
  • SPT Labtech Ltd
  • Standard BioTools Inc.
  • Sysmex Corporation
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Zymo Research Corporation
Product Code: MRR-9F52358C4167

The NGS Sample Preparation Market was valued at USD 2.40 billion in 2023, expected to reach USD 2.78 billion in 2024, and is projected to grow at a CAGR of 16.01%, to USD 6.80 billion by 2030.

Next-Generation Sequencing (NGS) sample preparation encompasses all necessary steps to prepare nucleic acids for sequencing, including extraction, purification, fragmentation, and library construction. This segment is indispensable to the overall NGS process, as it ensures sample quality and the accuracy of downstream results, facilitating applications in genomic research, medical diagnostics, and personalized medicine. With a rising demand in clinical diagnostics, infectious disease research, and cancer genomics, the NGS sample preparation market is witnessing significant growth. Key growth drivers include technological advancements delivering higher throughput and accuracy, a surge in genomic research, and the decreasing cost of sequencing. Additionally, the integration of artificial intelligence and automation in sample preparation processes presents lucrative opportunities for market players to enhance efficiency and reduce errors. However, market growth faces challenges such as the high initial setup cost, regulatory complexities, and the need for highly skilled personnel to run sophisticated NGS platforms. Small and medium-sized enterprises may find these barriers particularly prohibitive. Despite these challenges, innovation remains robust, with potential research areas including the development of standardized, user-friendly kits and consumables capable of handling diverse samples with greater efficiency. Companies are encouraged to focus on partnerships and collaborations to expand technological capabilities and integrate innovative approaches such as lab-on-a-chip systems for microfluidic sample preparation. Insight into the market reveals a competitive yet rapidly evolving landscape where staying at the forefront of technology and offering customizable and cost-effective solutions are vital for business growth. The nature of the NGS sample preparation market is dynamic, driven by continuous technological breakthroughs and an expanding array of applications, suggesting a promising future with opportunities for stakeholders willing to adapt and innovate accordingly.

KEY MARKET STATISTICS
Base Year [2023] USD 2.40 billion
Estimated Year [2024] USD 2.78 billion
Forecast Year [2030] USD 6.80 billion
CAGR (%) 16.01%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving NGS Sample Preparation Market

The NGS Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious diseases and rising need for early disease diagnosis
    • Favorable investment landscape in NGS for the research and development of new treatments
    • Emerging use of NGS sequencing technology in agriculture for sustainable productivity
  • Market Restraints
    • High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
  • Market Opportunities
    • Technological advancement in NGS sample preparation platforms
    • Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
  • Market Challenges
    • Limited availability of skilled professionals in medium and small size laboratories

Porter's Five Forces: A Strategic Tool for Navigating the NGS Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the NGS Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the NGS Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the NGS Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the NGS Sample Preparation Market

A detailed market share analysis in the NGS Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the NGS Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the NGS Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the NGS Sample Preparation Market

A strategic analysis of the NGS Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the NGS Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biological Materials Inc., Aurora Biomed Inc., Beckman Coulter by Danaher Corporation, BGI Group, Bio-Rad Laboratories, Inc., BioDynami, Eppendorf SE, Eurofins Genomics LLC, F. Hoffmann-La Roche Ltd., FORMULATRIX, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Macrogen Inc., Magen Biotechnology Co., Ltd., MCLAB, Merck KGaA, New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., Promega Corporation, Psomagen, Inc., Qiagen N.V., SPT Labtech Ltd, Standard BioTools Inc., Sysmex Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the NGS Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Reagents & Consumables and Workstations.
  • Based on Workflow, market is studied across DNA, Library Preparation, Quality Control, RNA, and Target Enrichment. The DNA is further studied across Human Whole Genome Sequencing (WGS), Targeted Sequencing, and Whole Exome Sequencing (WES). The RNA is further studied across Gene Expression Analysis and Whole Transcriptome Sequencing. The Target Enrichment is further studied across Targeted Seq, WES, and Whole Exome Sequencing (WES).
  • Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing by Synthesis (SBS), and Single-molecule real-time (SMRT) Sequencing.
  • Based on Application, market is studied across Agricultural & Animal Research, Disease Diagnostics, and Drug Discovery. The Disease Diagnostics is further studied across Cancer Diagnostics, Infectious Disease Diagnostics, and Reproductive Health Diagnostics.
  • Based on End-User, market is studied across Academic Institutes and Research Centers, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases and rising need for early disease diagnosis
      • 5.1.1.2. Favorable investment landscape in NGS for the research and development of new treatments
      • 5.1.1.3. Emerging use of NGS sequencing technology in agriculture for sustainable productivity
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in NGS sample preparation platforms
      • 5.1.3.2. Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled professionals in medium and small size laboratories
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. NGS Sample Preparation Market, by Product

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Workstations

7. NGS Sample Preparation Market, by Workflow

  • 7.1. Introduction
  • 7.2. DNA
    • 7.2.1. Human Whole Genome Sequencing (WGS)
    • 7.2.2. Targeted Sequencing
    • 7.2.3. Whole Exome Sequencing (WES)
  • 7.3. Library Preparation
  • 7.4. Quality Control
  • 7.5. RNA
    • 7.5.1. Gene Expression Analysis
    • 7.5.2. Whole Transcriptome Sequencing
  • 7.6. Target Enrichment
    • 7.6.1. Targeted Seq
    • 7.6.2. WES
    • 7.6.3. Whole Exome Sequencing (WES)

8. NGS Sample Preparation Market, by Technology

  • 8.1. Introduction
  • 8.2. Ion Semiconductor Sequencing
  • 8.3. Nanopore Sequencing
  • 8.4. Sequencing by Synthesis (SBS)
  • 8.5. Single-molecule real-time (SMRT) Sequencing

9. NGS Sample Preparation Market, by Application

  • 9.1. Introduction
  • 9.2. Agricultural & Animal Research
  • 9.3. Disease Diagnostics
    • 9.3.1. Cancer Diagnostics
    • 9.3.2. Infectious Disease Diagnostics
    • 9.3.3. Reproductive Health Diagnostics
  • 9.4. Drug Discovery

10. NGS Sample Preparation Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Institutes and Research Centers
  • 10.3. Hospitals & Clinics
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas NGS Sample Preparation Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific NGS Sample Preparation Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa NGS Sample Preparation Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Agilent enhances user experience in NGS sample preparation workflow
    • 14.3.2. INTEGRA Biosciences Acquires Miroculus
    • 14.3.3. Ultima Genomics Partners with New England Biolabs to Expand Research Applications on Ultima Sequencers
    • 14.3.4. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies
    • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 14.3.6. Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox
    • 14.3.7. NGS KAPA Target Enrichment Product Launch
    • 14.3.8. PerkinElmer Launches BioQule NGS System to Automate Library Preparation
    • 14.3.9. Introducing Tecan's MagicPrep NGS - the walkaway solution for your NGS library prep needs
    • 14.3.10. Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Applied Biological Materials Inc.
  • 3. Aurora Biomed Inc.
  • 4. Beckman Coulter by Danaher Corporation
  • 5. BGI Group
  • 6. Bio-Rad Laboratories, Inc.
  • 7. BioDynami
  • 8. Eppendorf SE
  • 9. Eurofins Genomics LLC
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. FORMULATRIX, Inc.
  • 12. Illumina, Inc.
  • 13. Integrated DNA Technologies, Inc.
  • 14. Macrogen Inc.
  • 15. Magen Biotechnology Co., Ltd.
  • 16. MCLAB
  • 17. Merck KGaA
  • 18. New England Biolabs, Inc.
  • 19. Novogene Co., Ltd.
  • 20. Oxford Nanopore Technologies PLC
  • 21. PerkinElmer Inc.
  • 22. Promega Corporation
  • 23. Psomagen, Inc.
  • 24. Qiagen N.V.
  • 25. SPT Labtech Ltd
  • 26. Standard BioTools Inc.
  • 27. Sysmex Corporation
  • 28. Takara Bio Inc.
  • 29. Tecan Trading AG
  • 30. Thermo Fisher Scientific Inc.
  • 31. Twist Bioscience Corporation
  • 32. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. NGS SAMPLE PREPARATION MARKET RESEARCH PROCESS
  • FIGURE 2. NGS SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. NGS SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. NGS SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NGS SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NGS SAMPLE PREPARATION MARKET DYNAMICS
  • TABLE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HUMAN WHOLE GENOME SEQUENCING (WGS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE EXOME SEQUENCING (WES), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQ, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE EXOME SEQUENCING (WES), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SEQUENCING BY SYNTHESIS (SBS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, B